Zobrazeno 1 - 10
of 2 316
pro vyhledávání: '"Kribben A"'
Publikováno v:
International Journal of Nephrology and Renovascular Disease, Vol Volume 14, Pp 399-410 (2021)
Malina Grube,1 Frank Weber,2 Anna Lena Kahl,3 Andreas Kribben,1 Nils Mülling,1 Walter Reinhardt1 1Department of Nephrology, University Hospital Essen, Essen, Germany; 2Department of General-, Visceral- and Transplantation Surgery, Section of Endocri
Externí odkaz:
https://doaj.org/article/b0db78fcc01a44d2bb13725fa836e6d3
Autor:
Lui Forni, Filippo Aucella, Gabriella Bottari, Stefan Büttner, Vincenzo Cantaluppi, Dietmar Fries, Jan Kielstein, Detlef Kindgen-Milles, Claus Krenn, Andreas Kribben, Andreas Meiser, Steffen Mitzner, Marlies Ostermann, Vedran Premuzic, Caroline Rolfes, Christina Scharf, Stefan Schunk, Zsolt Molnar, Alexander Zarbock
Publikováno v:
BMC Nephrology, Vol 25, Iss 1, Pp 1-8 (2024)
Abstract Background Rhabdomyolysis describes a syndrome characterized by muscle necrosis and the subsequent release of creatine kinase and myoglobin into the circulation. Myoglobin elimination with extracorporeal hemoadsorption has been shown to effe
Externí odkaz:
https://doaj.org/article/e43c1c0e14834eb4853cb41f800a0304
Autor:
Kristina Schönfelder, Lucas Kühne, Lena Schulte-Kemna, Jessica Kaufeld, Hana Rohn, Andreas Kribben, Bernd Schröppel, Paul T. Brinkkötter, Anja Gäckler
Publikováno v:
BMC Nephrology, Vol 25, Iss 1, Pp 1-8 (2024)
Abstract Background The complement factor 5 (C5)-inhibitor eculizumab has been established as standard-of-care for the treatment of atypical hemolytic uremic syndrome (aHUS). In 2021, the long-acting C5-inhibitor ravulizumab was approved, extending i
Externí odkaz:
https://doaj.org/article/064aa74fbb6e4cf0a385f7f62fede2f5
Autor:
Fabio Silvio Taccone, Frank Martin Brunkhorst, Gabriella Bottari, Jorge Hidalgo, Andreas Kribben, Jean-Louis Teboul, Dana Tomescu, Teresa Klaus, Joerg Scheier, Efthymios Deliargyris, Ricard Ferrer
Publikováno v:
JMIR Research Protocols, Vol 13, p e55880 (2024)
BackgroundExtracorporeal blood purification with CytoSorb has been increasingly used as an adjunctive therapy in several hyperinflammatory critical care conditions, as well as to remove elevated levels of myoglobin or bilirubin in patients with rhabd
Externí odkaz:
https://doaj.org/article/844c619529494d649017af11b45b8428
Autor:
Kristina Schönfelder, Birte Möhlendick, Ute Eisenberger, Andreas Kribben, Winfried Siffert, Falko M. Heinemann, Anja Gäckler, Benjamin Wilde, Justa Friebus-Kardash
Publikováno v:
Diagnostics, Vol 14, Iss 19, p 2202 (2024)
Background/Objectives: Our previous retrospective single-center cohort study found, at 3-year follow-up, a trend toward low tacrolimus trough levels and an increased risk of de novo donor-specific anti-HLA antibodies (DSAs) and of antibody-mediated r
Externí odkaz:
https://doaj.org/article/d93c3686f4fa4a33a24cacdf6a79f72e
Autor:
Kristina Boss, Margret Paar, Katja Waterstradt, Kerstin Schnurr, Philipp Ickerott, Ulrike Wieneke, Ralf Spitthöver, Karl Oettl, Andreas Kribben
Publikováno v:
BMC Nephrology, Vol 24, Iss 1, Pp 1-10 (2023)
Abstract Background and Aim Maintenance haemodialysis patients have increased morbidity and mortality which is mainly driven by an elevated inflammation level due to the uraemic milieu. A major part of this increased inflammation level is the degree
Externí odkaz:
https://doaj.org/article/b671b8fdab2b40178886043a20f6a0b3
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
European Journal of Medical Research, Vol 15, Iss 10, p 452 (2010)
Abstract Background Measuring arterial stiffness using pulse wave velocity (PWV) has become an important tool to assess vascular function and cardiovascular mortality. For subject with hypertension, end-stage renal disease and diabetes, PWV has been
Externí odkaz:
https://doaj.org/article/493d2aa4ee104939922cf3bb8d8795bd
Autor:
Egensperger Rupert, Kribben Andreas, Dzagnidze Anna, Liedert Bernd, Schäfers Maria, Obermann Mark, Katsarava Zaza, Yoon Min-Suk, Limmroth Volker, Diener Hans-Christoph, Thomale Juergen
Publikováno v:
BMC Neuroscience, Vol 10, Iss 1, p 77 (2009)
Abstract Background Cisplatin mediates its antineoplastic activity by formation of distinct DNA intrastrand cross links. The clinical efficacy and desirable dose escalations of cisplatin are restricted by the accumulation of DNA lesions in dorsal roo
Externí odkaz:
https://doaj.org/article/0f3cab2e44c24f228db24b933e7a660d